These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 29803825)

  • 1. A Delphi-Based Consensus Statement on the Management of Anticoagulated Patients With Botulinum Toxin for Limb Spasticity.
    Boulias C; Ismail F; Phadke CP; Bagg S; Bureau I; Charest S; Chen R; Cheng A; Ethans K; Fink M; Finlayson H; Gulasingam S; Guo M; Haziza M; Hosseini H; Khan O; Lang M; Lapp T; Leckey R; Li Pi Shan R; Liem N; Lo A; Mason M; McNeil S; McVeigh S; Miller T; Mills PB; Naud P; O'Connell C; Petitclerc M; Prevost J; Reebye R; Richardson D; Satkunam L; Sharma S; Short C; Sirois G; Unarket M; Wein T; Wilkins K; Winston P
    Arch Phys Med Rehabil; 2018 Nov; 99(11):2183-2189. PubMed ID: 29803825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges in the management of anticoagulated patients with focal spasticity.
    Boulias C; Ismail F; Phadke CP
    Toxicon; 2020 Apr; 177():93-95. PubMed ID: 32217235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of botulinum toxin treatment for spasticity and bleeding complications in patients with thrombotic risk.
    Phadke CP; Thanikachalam V; Ismail F; Boulias C
    Toxicon; 2017 Nov; 138():188-190. PubMed ID: 28919457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type A in post-stroke upper limb spasticity.
    Kaji R; Osako Y; Suyama K; Maeda T; Uechi Y; Iwasaki M;
    Curr Med Res Opin; 2010 Aug; 26(8):1983-92. PubMed ID: 20569068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial.
    Kaji R; Osako Y; Suyama K; Maeda T; Uechi Y; Iwasaki M;
    J Neurol; 2010 Aug; 257(8):1330-7. PubMed ID: 20358216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R; Akturk S; Ersoy Y
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OnabotulinumtoxinA for Lower Limb Spasticity: Guidance From a Delphi Panel Approach.
    Esquenazi A; Alfaro A; Ayyoub Z; Charles D; Dashtipour K; Graham GD; McGuire JR; Odderson IR; Patel AT; Simpson DM
    PM R; 2017 Oct; 9(10):960-968. PubMed ID: 28286053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.
    Baguley IJ; Nott MT; Turner-Stokes L; De Graaff S; Katrak P; McCrory P; de Abadal M; Hughes A
    J Rehabil Med; 2011 Nov; 43(11):1032-7. PubMed ID: 22031350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physician Preferences for Botulinum Toxin Injections in Anticoagulated Patients with Spasticity.
    Kassam A; Phadke CP; Ismail F; Boulias C
    Can J Neurol Sci; 2016 Jul; 43(4):581-3. PubMed ID: 26940640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Clinical Effects of Botulinum Toxin Intramuscular Injections for Spasticity.
    Phadke CP; Balasubramanian CK; Holz A; Davidson C; Ismail F; Boulias C
    Can J Neurol Sci; 2016 Mar; 43(2):298-310. PubMed ID: 26597813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of a 15-years' experience in including shoulder muscles, when treating upper-limb spasticity post-stroke with botulinum toxin type A.
    Carvalho MP; Pinto D; Gorayeb M; Jacinto J
    Top Stroke Rehabil; 2018 Apr; 25(3):194-202. PubMed ID: 29322885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
    Brashear A; Gordon MF; Elovic E; Kassicieh VD; Marciniak C; Do M; Lee CH; Jenkins S; Turkel C;
    N Engl J Med; 2002 Aug; 347(6):395-400. PubMed ID: 12167681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European consensus table on the use of botulinum toxin type A in adult spasticity.
    Wissel J; Ward AB; Erztgaard P; Bensmail D; Hecht MJ; Lejeune TM; Schnider P; Altavista MC; Cavazza S; Deltombe T; Duarte E; Geurts AC; Gracies JM; Haboubi NH; Juan FJ; Kasch H; Kätterer C; Kirazli Y; Manganotti P; Parman Y; Paternostro-Sluga T; Petropoulou K; Prempeh R; Rousseaux M; Slawek J; Tieranta N
    J Rehabil Med; 2009 Jan; 41(1):13-25. PubMed ID: 19197564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopenic consequences of botulinum toxin injections in the masticatory muscles: a pilot study.
    Raphael KG; Tadinada A; Bradshaw JM; Janal MN; Sirois DA; Chan KC; Lurie AG
    J Oral Rehabil; 2014 Aug; 41(8):555-63. PubMed ID: 24836732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment for flexed-elbow deformity during gait following botulinum toxin A treatment.
    Tanikawa H; Kagaya H; Inagaki K; Kotsuji Y; Suzuki K; Fujimura K; Mukaino M; Hirano S; Saitoh E; Kanada Y
    Gait Posture; 2018 May; 62():409-414. PubMed ID: 29649706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survey of Botulinum Toxin Injections in Anticoagulated Patients: Korean Physiatrists' Preference in Controlling Anticoagulation Profile Prior to Intramuscular Injection.
    Jang Y; Park GY; Park J; Choi A; Kim SY; Boulias C; Phadke CP; Ismail F; Im S
    Ann Rehabil Med; 2016 Apr; 40(2):279-87. PubMed ID: 27152278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle structure and stiffness assessment after botulinum toxin type A injection. A systematic review.
    Mathevon L; Michel F; Decavel P; Fernandez B; Parratte B; Calmels P
    Ann Phys Rehabil Med; 2015 Dec; 58(6):343-50. PubMed ID: 26602437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.
    Koman LA; Paterson Smith B; Balkrishnan R
    Paediatr Drugs; 2003; 5(1):11-23. PubMed ID: 12513103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of the current practice of intramuscular Botulinum toxin injections for hemiplegic shoulder pain in the UK.
    Holmes RJ; Connell LA
    Disabil Rehabil; 2019 Mar; 41(6):720-726. PubMed ID: 29126361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.